Results 181 to 190 of about 2,132,699 (356)

Reply : oral contraceptives and bone mineral density

open access: yes, 2001
Reply : oral contraceptives and bone mineral ...
Julie Pasco (13077054)   +2 more
core  

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

open access: yesCochrane Database of Systematic Reviews, 2015
R. Roach   +5 more
semanticscholar   +1 more source

Oral contraceptives and bone mineral density - Reply

open access: yes, 2001
Oral contraceptives and bone mineral density ...
GC Nicholson (14448297)   +2 more
core  

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

Oral contraceptives, migraine and quality of life

open access: yes, 2019
Oral contraceptives, migraine and quality of ...
Julie von Trepka Høiseth
core  

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy